
Abtika 60mg Tablet
Marketer
Abbott Healthcare Private Limited
Salt Composition
Ticagrelor (60mg)
Overview Abtika 60mg Tablet
CardioGuard 60mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the creation of dangerous blood clots within blood vessels, thus lowering the risk of heart attack or stroke in individuals with cardiovascular disease. CardioGuard 60mg is also indicated for patients recovering from a recent heart attack, experiencing severe angina (unstable chest pain), or post-stent placement. It mitigates the risk of recurrent heart attacks, strokes, and clot formation within stents. Concurrent use with aspirin, another antiplatelet medication, will be prescribed by your physician. CardioGuard 60mg can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even during periods of wellness, as discontinuation elevates the risk of recurrent cardiac events. The most frequent adverse effect is bleeding; injuries may bleed more profusely and for extended durations. While usually mild and self-limiting, persistent or excessive bleeding should be reported. Some patients experience mild dyspnea, which typically resolves with ongoing therapy; however, worsening or persistent shortness of breath requires medical attention. CardioGuard 60mg is contraindicated in individuals with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or hepatic impairment. Disclose any such conditions to your doctor prior to commencing treatment.
Uses of Abtika 60mg Tablet
Cardiovascular event prophylaxis
Major Benefits of Abtika 60mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Abtika 60mg Tablets can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Abtika 60mg Tablet:
- Bleeding
- Breathlessness
How to use Abtika 60mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Abtika 60mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Abtika 60mg Tablet works:
Plavix 60mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous blood clot development and subsequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Abtika 60mg Tablet concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Abtika 60mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on Abtika 60mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Abtika 60mg Tablet.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Abtika 60mg Tablet is considered safe for use, and no alteration in dosage is advised. Data regarding Abtika 60mg Tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Abtika 60mg tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Abtika 60mg tablet use; physician consultation is advised.
What if you forget to take Abtika 60mg Tablet :
Should you forget to take your Abtika 60mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Abtika 60mg Tablet
| Label | Value |
|---|---|
| Pharmaceutical Category | Triazole pyrimidine derivatives |
| Addictive | None. |
| Medication Classification | HEMATOLOGICAL |
| Mechanism of Action | Blockers of the P2Y12 adenosine diphosphate receptor |
